Company Filing History:
Years Active: 2018-2020
Title: Jeff Varelman: Innovator in Infectious Disease Treatment
Introduction
Jeff Varelman is a notable inventor based in Moyie Springs, ID (US). He has made significant contributions to the field of medicine, particularly in the treatment of infectious diseases. With a total of 2 patents, Varelman is recognized for his innovative formulations that address critical health challenges.
Latest Patents
Varelman's latest patents focus on the use of dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat infectious diseases. These formulations are designed to be effective against drug-resistant infectious diseases, including drug-resistant tuberculosis. The embodiments of his invention relate to formulations that combine DMSO with one or more therapeutic agents, showcasing his commitment to advancing medical treatments.
Career Highlights
Jeff Varelman is currently associated with Abela Pharmaceuticals, Inc., where he continues to develop and refine his innovative ideas. His work is pivotal in the ongoing fight against infectious diseases, and his contributions are recognized within the pharmaceutical community.
Collaborations
Some of Varelman's coworkers include Colette Cozean and Rodney L Benjamin. Their collaboration enhances the innovative environment at Abela Pharmaceuticals, Inc., fostering the development of groundbreaking treatments.
Conclusion
Jeff Varelman's work exemplifies the spirit of innovation in the medical field. His patents and ongoing research contribute significantly to the treatment of infectious diseases, making a lasting impact on public health.